Patients
Sites
Sponsors
About Us
News
Sites access
Onco access
EN
Last updated 45 days ago
Share
Empagliflozin for No-reflow Phenomenon in PCI for STEMI
162 patients around the world
Available in
Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
1
Research sites
162
Patients around the world
This study is for people with
Coronary heart disease
Acute myocardial infarction
Requirements for the patient
To 85 Years
All Gender
Medical requirements
Inclusion criteria
Acute myocardial infarction with ST-segment elevation.
Presentation to the institute within 12 hours of symptom onset.
Coronary angioplasty chosen as the reperfusion treatment for the subject.
Known diagnosis of diabetes or admission glucose >180 mg/dl.
Informed consent signed.
Exclusion criteria
Hemodynamically unstable subjects.
Subjects undergoing thrombolysis treatment in the current event.
History of coronary revascularization surgery.
Known allergy or hypersensitivity to Sodium-glucose co-transporter-2 (SGLT2) inhibitors.
History of recurrent urinary tract infections.
Known chronic kidney disease and estimated glomerular filtration rate (eGFR) < 20.
Ongoing treatment with any SGLT2 inhibitor.
Participation in another clinical trial or having participated in the week prior to recruitment.
For women of childbearing age: Current or planned pregnancy or lactation.
Sites
Instituto Nacional de Cardiologia Ignacio Chavez
Recruiting
Consult
View site
Juan Badiano 1, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México
View site
Consult
See details
Contact us
Contact us
Study
EMPA-PCI
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Study type
Interventional
Conditions
Acute myocardial infarction
Requirements
To 85 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06342141
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent